Paving the way for the introduction of new vaccines into developing countries

Expert Review of Vaccines

Volumn 4, Issue 2, 2005, Pages 147-150

  Chabalgoity, José A ^a  

^a Institute of Hygiene   (Uruguay)

Author keywords

Developing countries; Immunotherapies; R D; Vaccines

Indexed keywords

HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS B VACCINE; VACCINE;

BACTERIAL INFECTION; COMMERCIAL PHENOMENA; DEVELOPING COUNTRY; DRUG INDUSTRY; DRUG RESEARCH; HAEMOPHILUS INFLUENZAE TYPE B; HEPATITIS B; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL; PRIORITY JOURNAL; REVIEW; STREPTOCOCCUS PNEUMONIAE; VACCINATION; VIRUS INFECTION; WORLD HEALTH ORGANIZATION;

DEVELOPING COUNTRIES; DRUG INDUSTRY; HUMANS; IMMUNIZATION PROGRAMS; VACCINES; WORLD HEALTH ORGANIZATION;

EID: 17144423264     PISSN: 14760584     EISSN: None     Source Type: Journal    
DOI: 10.1586/14760584.4.2.147     Document Type: Review

References (1)

1. Milstien J. Regulatory pathways for developing market vaccines. Expert Rev. Vaccines 2(5), 599-601 (2003).